Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway (Q48522982)
Jump to navigation
Jump to search
scientific article published on 12 December 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway |
scientific article published on 12 December 2017 |
Statements
1 reference
Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway (English)
1 reference
Kevin Y Guo
1 reference
Lili Han
1 reference
Xinyu Li
1 reference
Andrew V Yang
1 reference
Jiaxiong Lu
1 reference
Shan Guan
1 reference
Hui Li
1 reference
Yang Yu
1 reference
Yanling Zhao
1 reference
Jianhua Yang
1 reference
Hong Zhang
1 reference
12 December 2017
1 reference
1 reference
8
1 reference
69
1 reference
114123-114135
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference